SEC Form 4 · accession 0001652252-17-000106
BIO-RAD LABORATORIES, INC. · BIO BIO.B
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John Goetz
Officer — EVP, Chief Operating Officer
Period of report
Sep 13, 2017
Accepted (ET)
Sep 14, 2017 · 7:26 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000012208
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Bio-Rad A Common Stock | Sep 13, 2017 | M | 650 | $107.32 | A | 66,067 | D | |
| Bio-Rad A Common Stock | Sep 13, 2017 | F | 491 | $220.47 | D | 65,576 | D | |
| Bio-Rad A Common Stock | Sep 13, 2017 | M | 640 | $117.00 | A | 66,216 | D | |
| Bio-Rad A Common Stock | Sep 13, 2017 | F | 497 | $220.47 | D | 65,719 | D | |
| Bio-Rad A Common Stock | Sep 13, 2017 | M | 1,200 | $119.54 | A | 66,919 | D | |
| Bio-Rad A Common Stock | Sep 13, 2017 | F | 938 | $220.47 | D | 65,981 | D | |
| Bio-Rad A Common Stock | Sep 13, 2017 | M | 1,600 | $139.56 | A | 67,581 | D | |
| Bio-Rad A Common Stock | Sep 13, 2017 | F | 1,320 | $220.47 | D | 66,261 | D | |
| Bio-Rad A Common Stock | Sep 13, 2017 | M | 1,600 | $159.32 | A | 67,861 | D | |
| Bio-Rad A Common Stock | Sep 13, 2017 | F | 1,388 | $220.47 | D | 66,473 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option (right to buy)F1 | $107.32 | Sep 13, 2017 | M | 650 | D | — | Sep 12, 2022 | Bio-Rad A Common Stock | 650 | 0 | D |
| Non-Qualified Stock Option (right to buy)F2 | $117.00 | Sep 13, 2017 | M | 640 | D | — | Sep 11, 2023 | Bio-Rad A Common Stock | 640 | 640 | D |
| Non-Qualified Stock Option (right to buy)F3 | $119.54 | Sep 13, 2017 | M | 1,200 | D | — | Sep 10, 2024 | Bio-Rad A Common Stock | 1,200 | 2,400 | D |
| Non-Qualified Stock Option (right to buy)F4 | $139.56 | Sep 13, 2017 | M | 1,600 | D | — | Sep 11, 2025 | Bio-Rad A Common Stock | 1,600 | 4,800 | D |
| Non-Qualified Stock Option (right to buy)F5 | $159.32 | Sep 13, 2017 | M | 1,600 | D | — | Sep 7, 2026 | Bio-Rad A Common Stock | 1,600 | 6,400 | D |
Explanation of responses
- F1The option vests in five equal annual installments beginning September 12, 2013.
- F2The option vests in five equal annual installments beginning September 11, 2014.
- F3The option vests in five equal annual installments beginning September 10, 2015.
- F4The option vests in five equal annual installments beginning September 11, 2016.
- F5The option vests in five equal annual installments beginning September 7, 2017.